Jim Simons acquired 615k 4D Molecular Therapeutics shares worth $7.55M. That's 0.01% of their equity portfolio (1151st largest holding). The investor owns 1.15% of the outstanding 4D Molecular Therapeutics stock. The first 4D Molecular Therapeutics trade was made in Q4 2021. Since then Jim Simons bought shares ten more times and sold shares on four occasions. The stake costed the investor $4.55M, netting the investor a gain of 66% so far.